VitaSpring Biomedical Co. Ltd.
VSBC · OTC
10/31/2022 | 7/31/2022 | 4/30/2022 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $3,066,822 | $3,407,580 | $3,097,800 | $2,891,280 |
| - Cash | $24 | $22 | $79 | $107 |
| + Debt | $330 | $376 | $420 | $464 |
| Enterprise Value | $3,067,128 | $3,407,934 | $3,098,141 | $2,891,637 |
| Revenue | $0 | $0 | $1,490 | $3,489 |
| % Growth | – | -100% | -57.3% | – |
| Gross Profit | -$4 | -$4 | $568 | $1,463 |
| % Margin | – | – | 38.1% | 41.9% |
| EBITDA | -$179 | -$170 | $347 | $1,192 |
| % Margin | – | – | 23.3% | 34.2% |
| Net Income | -$138 | -$144 | $277 | $941 |
| % Margin | – | – | 18.6% | 27% |
| EPS Diluted | -0.001 | -0.001 | 0.001 | 0.005 |
| % Growth | 0% | -153.8% | -71.7% | – |
| Operating Cash Flow | $2 | -$58 | -$28 | -$156 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | $2 | -$58 | -$28 | -$157 |